Basel Medical Group Ltd (BMGL) — Dilution Risk Analysis

Current Snapshot

Basel Medical Group Ltd (BMGL) has a DilutionWatch score of 44/10 and is classified as MEDIUM risk. The score date in the source data is 2026-10-03T03:45:52.527348.

This page is assembled from sourced share-structure, market-data, SEC-filing, and DilutionWatch fields. Missing values are left blank rather than estimated.

Share Structure

Shares Outstanding
18,785,750 Source
Public Float
6,017,076 Source
Float as % of Outstanding
32.0%

Dilution Risk Score

Score: 44/10 Source (as of 2026-10-03T03:45:52.527348)

Dilution Risk Drivers

DriverStored ValueSource
Three-year share count growth 1.79% Source

DilutionWatch Analysis

Risk Level
MEDIUM (Score: 44/10) Source
Share Count Growth (3-Year)
1.79% Source

What This Page Does Not Estimate

DilutionWatch does not infer missing cash runway, authorized share count, ATM capacity, shelf capacity, or share-growth values on this page. A blank field means the current source payload did not provide a usable value with provenance.

Scores and classifications are shown only when supplied by the DilutionWatch data layer. SEC filing rows link to their source accession when a filing URL is available.